Alanna Green

Joining the AXA IM Alts team in 2024, Alanna brings experience that sits at the intersection of investments and life sciences. Alanna previously spent two years at Eccleston Associates as an Investment Consultant, working on pan-European M&A transactions, corporate due diligence and strategy/transformation projects across multiple industries including Pharmaceuticals and Healthcare, Business Services and Software.

Alanna also worked at Eye2Gene and Dawn Pharma, two MedTech start-ups with a focus on artificial intelligence, diagnostics, and precision medicine.

Alanna holds an Msc in Bioscience Entrepreneurship from University College London, and a BSc in Cellular and Molecular Medicine from The University of Bristol.